Supplementary Appendix: Efficacy and safety analysis of a new oral testosterone undecanoate (TU) formulation following two years of treatment in hypogonadal men

<p>Supplementary Table 1. Change from Baseline in Efficacy and Safety Parameters over Two<br> Years of Oral TU Treatment &ndash; Confirmatory Analysis</p> <p>Supplementary Figure 1. Study Dose Titration Scheme for Days 0-180</p> <p>Supplementary Figure 2. Study Dose Titration Scheme for Days 180 and 270</p> <p>Supplementary Figure 3. Study Dose Titration Scheme for Days 365 Through End of Study</p>